Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
Author(s): G Torres-Ruiz , P Rojas-Flores , P Carrion Montaner , et al Added: 12 months ago

Anticoagulation

MI/ACS
Appropriateness of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome: Differences Between Unstable Angina and Acute Myocardial Infarction
Author(s): G Torres-Ruiz , P Rojas-Flores , N Mallofré Vila , et al Added: 12 months ago

MI/ACS
Author(s): Evangelos Giannitsis , Hugo A Katus Added: 3 years ago
Highly Sensitive Troponin T Assay and Diagnosis of Acute Myocardial Infarction According to the new definition of myocardial infarction (MI) issued by the European Society of Cardiology/American College of Cardiology (ESC/ACC) Committee for the Redefinition of Myocardial Infarction, acute MI has occurred when cardiac troponin (cTn) is present in the blood of a patient who also exhibits signs or… View more

MI/ACS
Research Area(s) / Expertise:
Antoni Martínez-Rubio
Research Area(s) / Expertise:

Atrial Fibrillation

Coronary Artery Disease and Myocardial Infarction
Dr Antoni Martinez Rubio , Jefe de Servicio de Cardiología del Hospital Parc Taulí de Sabadell (Barcelona, España).Dr Martínez-Rubio is on the Editorial Board of European Cardiology Review. View more
Evangelos Giannitsis
Research Area(s) / Expertise: Job title: Assistant Professor of Medicine in Heidelberg
Dr. Giannitsis, an Assistant Professor of Medicine based in Heidelberg, holds a medical degree from the University of Homburg. He pursued advanced training in internal medicine and cardiology at Lübeck University Hospital in Germany. Additionally, he completed a Ph.D. in internal medicine before assuming his current role in 2002. Dr. Giannitsis's research is centered on cardiac biomarkers,… View more
Air Pollution, Inflammatory Biomarkers and Infarct Size In STEMI Patients
Author(s): Laura Díaz-Chirón , Luis Negral , Laura Megido , et al Added: 2 years ago

Vascular Disease and Surgery
Author(s): Paul A Gurbel , David Kandzari Added: 3 years ago
The rare but catastrophic occurrence of stent thrombosis, in particular 'late' stent thrombosis, in association with deployment of drug-eluting stents has focused attention on the adequacy of the current dual anti-platelet regimen of aspirin and clopidogrel. Stent thrombosis is due to multiple factors. These include, specific stent features (delayed healing or polymer hypersensitivity),… View more

Anticoagulation

MI/ACS
Coronavirus Disease 2019 and Catheterisation Laboratory Considerations: “Looking for Essentials”
Author(s): Syed Haseeb Raza Naqvi , Madiha Fatima , Fady Gerges , et al Added: 3 years ago
The current coronavirus disease 2019 (COVID-19) outbreak is more than a health crisis, and its impact on the management of other diseases of various specialties is one of the greatest challenges facing healthcare professionals. Health associations worldwide are now recommending dealing with emergencies only, utilising telemedicine and providing ambulatory facilities, where available, for non… View more

COVID-19
Author(s): Sasha Koul , David Erlinge Added: 3 years ago
Acute coronary syndromes (ACS) are a major reason for death and morbidity in the industrialised world. One of the most successful treatments for ACS has been strategies to target the platelets and inhibit their function. Mechanisms of Platelet Activation Thrombus formation in the arteries is dependent on platelets and their ability to attach to the injured wall despite the rapid arterial blood… View more

Anticoagulation

MI/ACS